Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study

2022 . Cornberg, Markus | Ahumada, Adriana | Aghemo, Alessio | Andreoni, Massimo | Bhagat, Abhi | Butrymowicz, Isabel | Carmiel, Michal | Chodick, Gabriel | Conway, Brian | Song, Yanna | Gasbarrini, Antonio | Hüppe, Dietrich | Plaza, Francisco Jorquera | Lampertico, Pietro | Alonso, Maria Luisa Manzano | Myles, Lindsay | Persico, Marcello | Ramji, Alnoor | Sarrazin, Christoph | Villa, Erica | Weil, Clara | Otano, Juan Isidro Uriz